Human immunodeficiency virus (HIV)-induced neurotoxicity: roles for the NMDA receptor subtypes.

scientific article

Human immunodeficiency virus (HIV)-induced neurotoxicity: roles for the NMDA receptor subtypes. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1523/JNEUROSCI.4617-05.2006
P932PMC publication ID6675362
P698PubMed publication ID16421318

P50authorLauren A O'DonnellQ59698464
P2093author name stringMarc A Dichter
David R Lynch
Arpita Agrawal
Kelly L Jordan-Sciutto
Dennis L Kolson
P2860cites workFailures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insultsQ24558984
The calpain systemQ28185062
Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide.Q52121112
Study of receptor-mediated neurotoxins released by HIV-1-infected mononuclear phagocytes found in human brainQ71071921
Properties of inhibitory and excitatory synapses between hippocampal neurons in very low density culturesQ72486161
Calpain in the pathophysiology of spinal cord injury: neuroprotection with calpain inhibitorsQ73371207
HIV-1 coat protein neurotoxicity prevented by calcium channel antagonistsQ28334629
Cerebrospinal fluid quinolinic acid concentrations are increased in acquired immune deficiency syndromeQ28342032
Developmental and regional expression in the rat brain and functional properties of four NMDA receptorsQ28570615
Antagonists selective for NMDA receptors containing the NR2B subunit.Q33600248
Neuronal death induced by brain-derived human immunodeficiency virus type 1 envelope genes differs between demented and nondemented AIDS patientsQ33785357
HIV-1 infected mononuclear phagocyte secretory products affect neuronal physiology leading to cellular demise: relevance for HIV-1-associated dementia.Q33952997
Pathways to neuronal injury and apoptosis in HIV-associated dementia.Q34223078
NMDA receptor pharmacology: perspectives from molecular biologyQ34367696
Excitotoxicity: perspectives based on N-methyl-D-aspartate receptor subtypesQ34542359
Macrophage/microglial accumulation and proliferating cell nuclear antigen expression in the central nervous system in human immunodeficiency virus encephalopathyQ35098372
Evidence of apoptotic cell death in HIV encephalitisQ35795133
Ca2+-dependent proteases in ischemic neuronal death: a conserved 'calpain-cathepsin cascade' from nematodes to primatesQ35839939
N-methyl-D-aspartate receptor subtypes: multiple roles in excitotoxicity and neurological diseaseQ35999737
Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical culturesQ36233456
Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patientsQ37400137
Quinolinic acid production is related to macrophage tropic isolates of HIV-1.Q38920914
Apoptosis induced by infection of primary brain cultures with diverse human immunodeficiency virus type 1 isolates: evidence for a role of the envelope.Q39549145
Development of a human neuronal cell model for human immunodeficiency virus (HIV)-infected macrophage-induced neurotoxicity: apoptosis induced by HIV type 1 primary isolates and evidence for involvement of the Bcl-2/Bcl-xL-sensitive intrinsic apoptoQ39684509
Calpain inhibition prevents pacing-induced cellular remodeling in a HL-1 myocyte model for atrial fibrillation.Q40553022
Selective activation induced cleavage of the NR2B subunit by calpain.Q40607831
Specific proteolysis of the NR2 subunit at multiple sites by calpainQ40781019
Human immunodeficiency virus type 1-infected monocytic cells can destroy human neural cells after cell-to-cell adhesionQ41618088
Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1.Q41710744
Dendritic changes in the hippocampal formation of AIDS patients: a quantitative Golgi study.Q42452426
Regional patterns of brain metabolites in AIDS dementia complexQ42470182
Apoptotic neurons in brains from paediatric patients with HIV-1 encephalitis and progressive encephalopathy.Q42474345
Human brain parenchymal microglia express CD14 and CD45 and are productively infected by HIV-1 in HIV-1 encephalitisQ43436991
Hippocampal injury and alterations in neuronal chemokine co-receptor expression in patients with AIDS.Q43577438
Elevated cerebrospinal fluid quinolinic acid levels are associated with region-specific cerebral volume loss in HIV infectionQ43596644
Glutamate is a mediator of neurotoxicity in secretions of activated HIV-1-infected macrophagesQ43657062
Activation of NR1a/NR2B receptors by monocyte-derived macrophage secretory products: implications for human immunodeficiency virus type one-associated dementiaQ44404781
Direct binding properties of conantokins to native N-methyl-d-aspartate receptorsQ44445169
CSF quinolinic acid levels are determined by local HIV infection: cross-sectional analysis and modelling of dynamics following antiretroviral therapy.Q44795363
Role of NMDA receptor subtypes in governing the direction of hippocampal synaptic plasticityQ44895962
Correlation of in vivo neuroimaging abnormalities with postmortem human immunodeficiency virus encephalitis and dendritic lossQ45665036
Caspase cascades in human immunodeficiency virus-associated neurodegeneration.Q45732507
Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. HNRC Group. HIV Neurobehavioral Research Center.Q45749830
The regulation of quinolinic acid in human immunodeficiency virus-infected monocytesQ45768386
Human immunodeficiency virus-infected macrophages, gp120, and N-methyl-D-aspartate receptor-mediated neurotoxicityQ45773965
Selective neuronal vulnerability in HIV encephalitisQ46264554
Immunolocalization of calpain I-mediated spectrin degradation to vulnerable neurons in the ischemic gerbil brain.Q48108001
Neuronal and glial localization of NR1 and NR2A/B subunits of the NMDA receptor in the human cerebral cortexQ48224791
Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41.Q48830420
Development of neuronal sensitivity to toxins in cerebrospinal fluid from HIV-type 1-infected individuals.Q52064458
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectneurotoxicityQ3338704
toxic encephalopathyQ7830379
P304page(s)981-990
P577publication date2006-01-01
P1433published inJournal of NeuroscienceQ1709864
P1476titleHuman immunodeficiency virus (HIV)-induced neurotoxicity: roles for the NMDA receptor subtypes
P478volume26

Reverse relations

cites work (P2860)
Q37360100Activation of p38 MAPK is required in monocytic and neuronal cells for HIV glycoprotein 120-induced neurotoxicity
Q42069973Adenosine triphosphate released from HIV-infected macrophages regulates glutamatergic tone and dendritic spine density on neurons
Q37592018Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous system
Q34009735Apelin deficiency accelerates the progression of amyotrophic lateral sclerosis.
Q40085897Apelin, an endogenous neuronal peptide, protects hippocampal neurons against excitotoxic injury.
Q52720530BACE1 Mediates HIV-Associated and Excitotoxic Neuronal Damage Through an APP-Dependent Mechanism.
Q33614467Brain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individuals
Q35207533CCR5 knockout prevents neuronal injury and behavioral impairment induced in a transgenic mouse model by a CXCR4-using HIV-1 glycoprotein 120
Q40528935CXCL12-induced neurotoxicity critically depends on NMDA receptor-gated and L-type Ca(2+) channels upstream of p38 MAPK.
Q33387262Calpain and proteasomal regulation of antiretroviral zinc finger protein OTK18 in human macrophages: visualization in live cells by intramolecular FRET.
Q37857282Calpain inhibitors: a survey of compounds reported in the patent and scientific literature
Q39319848Calpain-cleaved type 1 inositol 1,4,5-trisphosphate receptor impairs ER Ca(2+) buffering and causes neurodegeneration in primary cortical neurons
Q37404160Calpain-mediated degradation of MDMx/MDM4 contributes to HIV-induced neuronal damage
Q24654460Cellular interplay between neurons and glia: toward a comprehensive mechanism for excitotoxic neuronal loss in neurodegeneration
Q34466521Cerebral metabolite changes prior to and after antiretroviral therapy in primary HIV infection
Q34508049Change in brain magnetic resonance spectroscopy after treatment during acute HIV infection
Q37239075Coupling diverse routes of calcium entry to mitochondrial dysfunction and glutamate excitotoxicity
Q39943009Decreased neuronal autophagy in HIV dementia: a mechanism of indirect neurotoxicity
Q35927911Differential regulation of macrophage phenotype by mature and pro-nerve growth factor
Q36881509Differential roles for caspase-mediated and calpain-mediated cell death in 1- and 3-week-old rat cortical cultures
Q35522971Dimethyl fumarate, an immune modulator and inducer of the antioxidant response, suppresses HIV replication and macrophage-mediated neurotoxicity: a novel candidate for HIV neuroprotection
Q28473257Disruption of neuronal autophagy by infected microglia results in neurodegeneration
Q92707791Dysregulation of BDNF/TrkB signaling mediated by NMDAR/Ca2+/calpain might contribute to postoperative cognitive dysfunction in aging mice
Q35177482E2F1 in neurons is cleaved by calpain in an NMDA receptor-dependent manner in a model of HIV-induced neurotoxicity
Q33987434E2F1 localizes predominantly to neuronal cytoplasm and fails to induce expression of its transcriptional targets in human immunodeficiency virus-induced neuronal damage
Q28660034Effects of opiates and HIV proteins on neurons: the role of ferritin heavy chain and a potential for synergism
Q58566604Enhanced facilitation and diminished inhibition characterizes the pronociceptive endogenous pain modulatory balance of persons living with HIV and chronic pain
Q37086459Enhancement of NMDA receptor-mediated excitatory postsynaptic currents by gp120-treated macrophages: implications for HIV-1-associated neuropathology.
Q35567289Eradication of human immunodeficiency virus from brain reservoirs
Q36950047Genetic knockouts suggest a critical role for HIV co-receptors in models of HIV gp120-induced brain injury
Q33903612Glutamate metabolism and HIV-associated neurocognitive disorders
Q33882450HIV and SIV induce alterations in CNS CaMKII expression and activation: a potential mechanism for cognitive impairment.
Q40412103HIV-1 Glycoprotein 120 Enhancement of N-Methyl-D-Aspartate NMDA Receptor-Mediated Excitatory Postsynaptic Currents: Implications for HIV-1-Associated Neural Injury.
Q43251339HIV-1 clade-specific differences in the induction of neuropathogenesis
Q48471986HIV-1 coreceptors CCR5 and CXCR4 both mediate neuronal cell death but CCR5 paradoxically can also contribute to protection
Q36009246HIV-1-related central nervous system disease: current issues in pathogenesis, diagnosis, and treatment
Q34037622HIV-associated neurocognitive disorder: pathogenesis and therapeutic opportunities
Q37038443HIV-infected macrophages mediate neuronal apoptosis through mitochondrial glutaminase
Q36200369HIV-infected microglia mediate cathepsin B-induced neurotoxicity.
Q34311736Heme oxygenase-1 deficiency accompanies neuropathogenesis of HIV-associated neurocognitive disorders
Q34139883Heme oxygenase-1 dysregulation in the brain: implications for HIV-associated neurocognitive disorders.
Q38122650Human immunodeficiency virus-associated depression: contributions of immuno-inflammatory, monoaminergic, neurodegenerative, and neurotrophic pathways
Q33582709IFNβ Protects Neurons from Damage in a Murine Model of HIV-1 Associated Brain Injury
Q36086223Induction of Heme Oxygenase-1 Deficiency and Associated Glutamate-Mediated Neurotoxicity Is a Highly Conserved HIV Phenotype of Chronic Macrophage Infection That Is Resistant to Antiretroviral Therapy
Q39692178La Crosse virus (LACV) Gc fusion peptide mutants have impaired growth and fusion phenotypes, but remain neurotoxic
Q24318325MicroRNA-21 dysregulates the expression of MEF2C in neurons in monkey and human SIV/HIV neurological disease
Q36950000Mitogen-activated protein kinase p38 in HIV infection and associated brain injury
Q38295226NMDA receptor modulation by the neuropeptide apelin: implications for excitotoxic injury
Q48241774NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo
Q90707715Neuroinflammation and EIF2 Signaling Persist despite Antiretroviral Treatment in an hiPSC Tri-culture Model of HIV Infection
Q37721505Neuronal Stress and Injury Caused by HIV-1, cART and Drug Abuse: Converging Contributions to HAND.
Q93142905Novel Positive Allosteric Modulators of Glutamate Transport Have Neuroprotective Properties in an in Vitro Excitotoxic Model
Q35659668Oxygen matters: tissue culture oxygen levels affect mitochondrial function and structure as well as responses to HIV viroproteins.
Q34970388Parallel high throughput neuronal toxicity assays demonstrate uncoupling between loss of mitochondrial membrane potential and neuronal damage in a model of HIV-induced neurodegeneration
Q34995472Site-specific hyperphosphorylation of pRb in HIV-induced neurotoxicity
Q34615745Soybean-derived Bowman-Birk inhibitor inhibits neurotoxicity of LPS-activated macrophages
Q90479185The Protective Effects and Mechanisms of Apelin/APJ System on Ischemic Stroke: A Promising Therapeutic Target
Q26752661Understanding Neuropsychiatric Diseases, Analyzing the Peptide Sharing between Infectious Agents and the Language-Associated NMDA 2A Protein
Q89493814Untreated Patients Dying With AIDS Have Loss of Neocortical Neurons and Glia Cells

Search more.